NCT04419623 2021-05-12A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With CancerTelios Pharma, Inc.Phase 1 Completed7 enrolled
NCT04564040 2020-12-29A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for RabeprazoleAstraZenecaPhase 1 Completed20 enrolled